Month: August 2020

DAVIS, Calif., Aug. 20, 2020 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced that management will present at the LD 500 virtual investor conference, hosted by LD Micro and taking place virtually September 1 – 4, 2020.Jim Boyd, Chief Financial Officer of Marrone Bio, is scheduled to host a virtual presentation during the conference as follows and will participate in one-on-one meetings with Chief Executive Officer Kevin Helash throughout the day.LD 500 Virtual Investor ConferenceDate: Wednesday, September 2, 2020  Time: 1:20 p.m. Eastern time (10:20 a.m. Pacific time) – Track 1  Webcast: https://www.webcaster4.com/Webcast/Page/2019/36186A...

LOS ANGELES, Aug. 20, 2020 (GLOBE NEWSWIRE) — Barfresh Food Group, Inc. (the “Company” or “Barfresh”) (OTCQB: BRFH), a manufacturer of frozen, ready-to-blend and ready-to-drink beverages, today announced that Riccardo Delle Coste, the Company’s Chief Executive Officer, will present virtually at The LD 500 Virtual Conference on Wednesday, September 2, 2020 at 4:40 p.m. ET. Management will also be available for one-on-one virtual meetings on September 2, 2020. To schedule a meeting with Barfresh, please contact your LD Micro sales representative.About Barfresh Food GroupBarfresh Food Group, Inc. (OTCQB: BRFH) is a developer, manufacturer and distributor of ready-to-blend and ready-to-drink beverages, including smoothies, shakes and frappes, primarily for restaurant chains and the foodservice industry. The company’s proprietary,...

SAN DIEGO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients, announces that President and CEO Michael Nall will present at the Proactive One2One Virtual Investor Forum, North America on Tuesday, August 25 at 1:00 p.m. Eastern time (10 a.m. Pacific time). The virtual event will include a brief company overview followed by a fully interactive Q&A session.  The live event can be accessed here and will be archived on the Investor Relations section of the Biocept website.About BioceptBiocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company uses its proprietary...

TORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC; Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”), an exploration company with a portfolio of properties in Northern Ontario and Santa Cruz, Argentina is pleased to report the six and three months financial results for fiscal 2020 and 2019, as summarized below:For full details, please visit us at www.platogold.com.About Plato Gold Corp.Plato Gold Corp. is a Canadian exploration company listed on the TSX Venture Exchange with projects in Marathon Ontario, Timmins Ontario and Santa Cruz, Argentina.The Good Hope Niobium Project consists of a total of 254 claims, consisting of 227 Single Cell Mining Claims and 27 Boundary Cell Mining Claims, and covers an area of approximately 5,146 hectares in Killala Lake Area and Cairngorm Lake Area Townships, near Marathon...

CALGARY, Alberta, Aug. 20, 2020 (GLOBE NEWSWIRE) — Tornado Global Hydrovacs Ltd. (“Tornado” or the “Company”) (TGH: TSX-V) today reported its unaudited condensed consolidated financial results for the Three and Six Month periods ended June 30, 2020. The unaudited condensed consolidated financial statements and MD&A have been filed on SEDAR and can be reviewed at www.sedar.com and on the Company’s web site www.tornadotrucks.com. Financial and Operating Highlights (in CAD $000’s except per share data)1 Earnings (loss) before interest, tax, depreciation, amortization  and stock-based compensation (“EBITDAS”) and earnings (loss) before interest and tax (“EBIT”) are not defined by IFRS. The definition of EBITDAS does not consider gains and losses on the disposal of assets, fair value changes in foreign currency forward contracts...

ROCHESTER, N.Y., Aug. 20, 2020 (GLOBE NEWSWIRE) — VerifyMe, Inc. (NASDAQ: VRME), a digital technology solutions provider specializing in brand protection functions such as; counterfeit prevention, authentication, serialization, track and trace features for labels, packaging and products, and Corsearch, Inc., a brand clearance and protection leader, are pleased to announce a collaboration that will support brands to reduce the global multi-billion dollar economic impact resulting from counterfeiting and piracy activities.The relationship will enhance enforcement capabilities for brands through the proactive identification and removal of unauthorized websites, domains, and products bearing the genuine intellectual property of legitimate companies.VerifyMe and Corsearch will work together to offer technologies and services that better...

EAGAN, Minn., Aug. 20, 2020 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is excited to announce that its Soluble Biotech division, a provider of soluble and stable formulations for proteins, just received its first substantial contract from a major pharmaceutical company since being acquired by Predictive Oncology in May 2020. The project involves protein expression followed by solubility studies, areas of significant expertise within Soluble Biotech.“Our first contract is a major milestone and validates our recent move into a new, larger facility”, says Dr. Larry DeLucas, former NASA astronaut and founder of Soluble Biotech. “We quadrupled our laboratory and office space, some of which will eventually...

VANCOUVER, British Columbia, Aug. 20, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to welcome Grant Larsen to the Aequus Team as Chief Commercial Officer, beginning August 17th, 2020.Mr. Larsen brings almost 20 years of senior management positions in North American Eyecare. His in-depth knowledge of Canadian Optometry, direct to consumer marketing, online technology and medical devices, brings important experience to accelerate growth for Aequus’ expanding portfolio of products. Mr. Larsen has a strong background in strategic leadership, most recently as the past CEO of Eye Recommend, one of Canada’s largest cooperatives of optometrists. In addition,...

– Fiscal First Quarter 2021 Revenue Increases 125% to $9.7 Million –– Largest Backlog in Company History Increases to $45 Million –SCOTTSDALE, Ariz., Aug. 20, 2020 (GLOBE NEWSWIRE) — AMMO, Inc. (OTCQB: POWW) (“AMMO” or the “Company”), a premier American ammunition and munition components manufacturer and technology leader, has reported financial results for its fiscal first quarter ended June 30, 2020.Financial Summary for Fiscal First Quarter 2021 vs. Fiscal First Quarter 2020Total revenue increased 125% to $9.7 million compared to $4.3 million.º Proprietary ammunition revenue increased 856% to $1.9 million.º Standard ammunition revenue increased 379% to $4.5 million.º Casing revenue increased 3% to $3.2 million.Net loss improved to $3.1 million compared to a net loss of $3.8 million.Adjusted EBITDA improved to $(0.3) million compared...

PARSIPPANY, NJ, Aug. 20, 2020 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) on August 18, 2020 received notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, due to the delay in the filing of the Company’s Form 10-Q for the quarterly period ended June 30, 2020 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), Interpace does not currently satisfy Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all periodic reports with the SEC. The deficiency has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.In accordance with the Nasdaq Listing Rules, Interpace was provided 60 calendar days to submit its plan to evidence compliance with the filing requirement...